192 related articles for article (PubMed ID: 16835310)
1. Comment: frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients.
Wall GC; Krypel L
Ann Pharmacother; 2006; 40(7-8):1473-4; author reply 1474. PubMed ID: 16835310
[No Abstract] [Full Text] [Related]
2. Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients.
Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein AC; Gunter MJ; Lafata JE; Harrold L; Nelson WW; Platt R
Ann Pharmacother; 2006 Mar; 40(3):386-91. PubMed ID: 16478808
[TBL] [Abstract][Full Text] [Related]
3. Febuxostat versus allopurinol for gout.
Gelber AC
N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
[No Abstract] [Full Text] [Related]
4. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
5. A review of inpatients with adverse drug reactions to allopurinol.
Khoo BP; Leow YH
Singapore Med J; 2000 Apr; 41(4):156-60. PubMed ID: 11063179
[TBL] [Abstract][Full Text] [Related]
6. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
Dalbeth N; Kumar S; Stamp L; Gow P
J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
[TBL] [Abstract][Full Text] [Related]
7. [Gout: diagnosis and therapy].
Schlapbach P
Ther Umsch; 1985 Oct; 42(10):687-90. PubMed ID: 3909489
[No Abstract] [Full Text] [Related]
8. Managing gout: how is it different in patients with chronic kidney disease?
El-Zawawy H; Mandell BF
Cleve Clin J Med; 2010 Dec; 77(12):919-28. PubMed ID: 21147946
[TBL] [Abstract][Full Text] [Related]
9. Opportunities for improving medication use and monitoring in gout.
Singh JA; Hodges JS; Asch SM
Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
[TBL] [Abstract][Full Text] [Related]
10. [Febuxostat or allopurinol in patients with gout : Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)].
Alten R; Mischkewitz M; Nitschmann S
Internist (Berl); 2020 May; 61(5):530-532. PubMed ID: 32130437
[No Abstract] [Full Text] [Related]
11. [Agranulocytosis secondary to a treatment with tisopurine].
Krulik M; Fkeury J; Audebert AA; Zylberait D; Debray J
Nouv Presse Med; 1980 Sep; 9(33):2351. PubMed ID: 7433031
[No Abstract] [Full Text] [Related]
12. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
Dalbeth N; Stamp L
Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
[TBL] [Abstract][Full Text] [Related]
13. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims.
Riedel AA; Nelson M; Joseph-Ridge N; Wallace K; MacDonald P; Becker M
J Rheumatol; 2004 Aug; 31(8):1575-81. PubMed ID: 15290738
[TBL] [Abstract][Full Text] [Related]
14. Allopurinol-induced DRESS syndrome.
Markel A
Isr Med Assoc J; 2005 Oct; 7(10):656-60. PubMed ID: 16259349
[TBL] [Abstract][Full Text] [Related]
15. Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings.
Pandya BJ; Riedel AA; Swindle JP; Becker LK; Hariri A; Dabbous O; Krishnan E
Curr Med Res Opin; 2011 Apr; 27(4):737-44. PubMed ID: 21271794
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol: a necessary evil.
Lim AY; Teng GG
Singapore Med J; 2009 Sep; 50(9):925-6; author reply 927. PubMed ID: 19787189
[No Abstract] [Full Text] [Related]
17. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
Iakunina IA; Barskova VG; Nasonova VA
Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
[No Abstract] [Full Text] [Related]
18. Colchicine prescribing in patients with gout.
Dalbeth N; Gow P;
N Z Med J; 2011 Jul; 124(1339):107-8. PubMed ID: 21952339
[No Abstract] [Full Text] [Related]
19. Safety and efficacy of allopurinol in chronic kidney disease.
Thurston MM; Phillips BB; Bourg CA
Ann Pharmacother; 2013 Nov; 47(11):1507-16. PubMed ID: 24259601
[TBL] [Abstract][Full Text] [Related]
20. How should we treat tophaceous gout in patients with allopurinol hypersensitivity?
Grahame R; Simmonds HA; McBride MB; Marsh FP
Adv Exp Med Biol; 1998; 431():19-23. PubMed ID: 9598024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
